Pressure Biosciences Inc (OTCMKTS:PBIO) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.91 and traded as high as $2.76. Pressure Biosciences shares last traded at $2.76, with a volume of 110 shares.
Separately, ValuEngine raised Pressure Biosciences from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd.
The firm has a 50 day simple moving average of $2.91. The company has a market capitalization of $5.96 million, a price-to-earnings ratio of -0.19 and a beta of 1.13.
Pressure Biosciences Company Profile (OTCMKTS:PBIO)
Pressure BioSciences, Inc develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources.
Further Reading: What is a front-end load?
Receive News & Ratings for Pressure Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.